Lv4
510 积分 2024-09-05 加入
EULAR recommendations for the treatment of systemic sclerosis: 2023 update
13小时前
已完结
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
14小时前
已完结
Semaglutide for the treatment of obesity
7天前
已完结
272-OR: Weight Loss with Time-Restricted Feeding or Treatment with Obeticholic Acid/Semaglutide Combination Have a Different Impact on Nonalcoholic Steatohepatitis in Diet-Induced Obese Mice
14天前
已关闭
GLP-1-based medications: Mechanisms involved in obesity treatment
17天前
已完结
GLP-1 physiology informs the pharmacotherapy of obesity
17天前
已完结
Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
19天前
已完结
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
19天前
已完结
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors
21天前
已完结
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
1个月前
已完结
皖公网安备34019202002308
